I reported previously (see here) on two Israeli startups developing blood tests for diagnosing early stage lung cancer.  Here is another – Savicell, achieving a 91% success rate. Early detection gives the patient a 50-80% recovery chance.  At late stage it is only 4%.

https://www.algemeiner.com/2018/12/20/israeli-company-creates-successful-blood-test-for-lung-cancer/

https://link.springer.com/article/10.1007/s00262-018-2173-5  http://www.savicell.com/